scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Carlo Caffarelli | Q90751867 |
Fabrizio Franceschini | Q102381539 | ||
Francesca Saretta | Q102381541 | ||
Silvia Caimmi | Q102381544 | ||
Lucia Liotti | Q102381546 | ||
Roberto Bernardini | Q114418114 | ||
Fabio Cardinale | Q114418118 | ||
Giuseppe Crisafulli | Q114418135 | ||
Paolo Bottau | Q114418159 | ||
Amelia Licari | Q38644153 | ||
Gian Luigi Marseglia | Q57046049 | ||
P2093 | author name string | Francesco Paravati | |
Giovanni Corsello | |||
Marcello Bergamini | |||
Iria Neri | |||
Cristiana De Ranieri | |||
Francesca Mori | |||
Alberto Villani | |||
Massimo Barbagallo | |||
Marzia Duse | |||
Giovanni Simeone | |||
Andrea Diociaiuti | |||
Fernanda Chiera | |||
Maya El Hachem | |||
Carla Mastrorilli | |||
Massimo Gola | |||
Dora Di Mauro | |||
Domenico Minasi | |||
Filomena Bugliaro | |||
Aurelia Pantaleo | |||
Carlo Filippo Tesi | |||
P2860 | cites work | Autologous serum skin test in chronic idiopathic urticaria: prevalence, correlation and clinical implications | Q79910237 |
Clinical features and natural history of physical urticaria in children | Q80427079 | ||
H1-antihistamines for chronic spontaneous urticaria | Q24187983 | ||
Histamine H2-receptor antagonists for urticaria | Q24201100 | ||
Guideline of Chronic Urticaria Beyond | Q26743369 | ||
Skin prick test to foods in childhood atopic eczema: pros and cons | Q26998267 | ||
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies | Q27861031 | ||
Aquagenic urticaria: diagnostic and management challenges | Q28069329 | ||
Natural course of physical and chronic urticaria and angioedema in 220 patients | Q28213614 | ||
Is there a role for antileukotrienes in urticaria? | Q28217673 | ||
Physical urticaria | Q28259467 | ||
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS). | Q30244845 | ||
The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria | Q31016831 | ||
Heat urticaria: a revision of published cases with an update on classification and management | Q33166940 | ||
Blastocystis and urticaria: Examination of subtypes and morphotypes in an unusual clinical manifestation | Q33465063 | ||
Angioedema in the emergency department: a practical guide to differential diagnosis and management | Q33559121 | ||
Urticaria and infections | Q33581685 | ||
Leukotriene receptor antagonists for chronic urticaria: a systematic review | Q33593785 | ||
Clinical characteristics of cholinergic urticaria in Korea | Q33682129 | ||
IgE mediated autoallergy against thyroid peroxidase--a novel pathomechanism of chronic spontaneous urticaria? | Q33885869 | ||
Increased risk of major depression subsequent to a first-attack and non-infection caused urticaria in adolescence: a nationwide population-based study | Q33928133 | ||
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. | Q34035726 | ||
IgE-mediated allergy: a rare cause of chronic spontaneous urticarial with allergen-specific immunotherapy as treatment option - a systematic review with meta-analysis from China | Q34050667 | ||
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria | Q34200855 | ||
Characteristics and prognosis of idiopathic solar urticaria: a cohort of 87 cases | Q34230598 | ||
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy | Q34354169 | ||
Chronic spontaneous urticaria and internal parasites--a systematic review. | Q34504507 | ||
Chronic urticaria and associated coeliac disease in children: a case-control study | Q81064248 | ||
Impact of contact sensitization in chronic spontaneous urticaria | Q83202586 | ||
Cancer risk in patients with chronic urticaria: a population-based cohort study | Q83256977 | ||
Treatment of autoimmune urticaria with low-dose cyclosporin A: A one-year follow-up | Q83291120 | ||
Hypersensitivity to lipid transfer protein is frequently associated with chronic urticaria | Q83629173 | ||
Blood pressure monitoring in children undergoing food challenge: association with anaphylaxis | Q83792052 | ||
Evidence for methotrexate as a useful treatment for steroid-dependent chronic urticaria | Q83820328 | ||
Analysis of serum total IgE, specific IgE and eosinophils in children with acute and chronic urticaria | Q84072571 | ||
Identification of the etiologies of chronic urticaria in children: a prospective study of 94 patients | Q84126511 | ||
Elevated serum total IgE--a potential marker for severe chronic urticaria | Q84259004 | ||
Chronic urticaria and autoimmunity in children | Q84538184 | ||
Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria | Q84758598 | ||
Efficacy of atorvastatin and antihistamines in comparison with antihistamines plus placebo in the treatment of chronic idiopathic urticaria: a controlled clinical trial | Q84934457 | ||
[Italian guidelines on chronic hives in pediatric age] | Q84946842 | ||
Severity of acute and chronic urticaria correlates with D-dimer level, but not C-reactive protein or total IgE | Q85264862 | ||
[Effects of yiqi huoxue qufeng decoction on the diamine oxidase and immunoglobin E of patients with chronic urticaria] | Q85548759 | ||
Successful omalizumab treatment of severe solar urticaria in a 6-year-old child | Q85588919 | ||
Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, open, parallel-group study | Q85749939 | ||
Challenge-proven aspirin hypersensitivity in children with chronic spontaneous urticaria | Q85888818 | ||
Treatment of Severe Cold-Induced Urticaria in a Child With Omalizumab | Q86002768 | ||
Diagnostic accuracy of patch test in children with food allergy | Q86991241 | ||
The significance of hypersensitivity to autologous sweat and serum in cholinergic urticaria: cholinergic urticaria may have different subtypes | Q87457746 | ||
Neuroendocrinology of the skin | Q87741568 | ||
The predictive factors for remission of chronic spontaneous urticaria in childhood: Outcome from a prospective study | Q88031458 | ||
Chronic spontaneous urticaria in an 8-year-old girl treated with omalizumab | Q88592003 | ||
Chronic urticaria and atopic disorders: a cross-sectional study of 11 271 patients | Q89932252 | ||
Epidemiology of Frequently Occurring Skin Diseases in Italian Children from 2006 to 2012: A Retrospective, Population-Based Study | Q41065570 | ||
Sedative effects of antihistamines: safety, performance, learning, and quality of life | Q41399135 | ||
Aquagenic Urticaria Diagnosed by the Water Provocation Test and the Results of Histopathologic Examination | Q42087284 | ||
An open-label, multicentre study of levocetirizine for the treatment of allergic rhinitis and urticaria in Taiwanese patients | Q42728846 | ||
Usefulness of a short course of oral prednisone in antihistamine-resistant chronic urticaria: a retrospective analysis | Q42859379 | ||
Safety and tolerability of levocetirizine dihydrochloride in infants and children with allergic rhinitis or chronic urticaria | Q42916709 | ||
Clinical observation on the treatment of chronic urticaria with total glucosides of paeony capsule combined with citirizine | Q42941832 | ||
Modern approaches to the diagnosis and treatment of cold contact urticaria | Q43072441 | ||
Peanut allergy saves a patient with cold-induced hypotension and urticaria. | Q43200153 | ||
Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity | Q43252701 | ||
Effects of a pseudoallergen-free diet on chronic spontaneous urticaria: a prospective trial | Q43268586 | ||
Experience with cyclosporine in children with chronic idiopathic urticaria | Q43290172 | ||
Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine | Q43414151 | ||
Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria | Q43503625 | ||
Contemporary approaches to the diagnosis and management of physical urticaria | Q43559681 | ||
Prevalence of sensitivity to food and drug additives in patients with chronic idiopathic urticaria | Q43743804 | ||
Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity | Q44123873 | ||
Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. | Q44584875 | ||
D-dimer: a biomarker for antihistamine-resistant chronic urticaria | Q44788597 | ||
Clinical features and anaphylaxis in children with cold urticaria | Q44827173 | ||
Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study | Q44834103 | ||
Anisakis simplex hypersensitivity is associated with chronic urticaria in endemic areas | Q44929525 | ||
High prevalence of autoimmune urticaria in children with chronic urticaria | Q45103534 | ||
Management of chronic spontaneous urticaria in real life--in accordance with the guidelines? A cross-sectional physician-based survey study | Q45223665 | ||
Practical algorithm for diagnosing patients with recurrent wheals or angioedema | Q45347035 | ||
The investigation of chronic urticaria in childhood: which investigations are being performed and which are recommended? | Q45816158 | ||
Support groups for children and their families in pediatric dermatology. | Q45965822 | ||
Safety of levocetirizine treatment in young atopic children: An 18-month study | Q46268615 | ||
Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes | Q46637550 | ||
Comparative study of systemic psoralen and ultraviolet A and narrowband ultraviolet B in treatment of chronic urticaria. | Q46855821 | ||
Guidelines for evaluation and management of urticaria in adults and children | Q46894770 | ||
Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients | Q47257091 | ||
Longitudinal Study of Pediatric Urticaria Pigmentosa. | Q47336561 | ||
Is Anisakis simplex responsible for chronic urticaria? | Q47382795 | ||
Phenotypical characterization of children with hypersensitivity reactions to NSAIDs. | Q47660485 | ||
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both | Q47684085 | ||
Evaluating Comorbidities, Natural History, and Predictors of Early Resolution in a Cohort of Children With Chronic Urticaria | Q47707567 | ||
Chronic urticaria caused by allergy to peach lipid transfer protein | Q47724754 | ||
The autologous serum skin test in the follow-up of patients with chronic urticaria | Q47866320 | ||
Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases | Q47883741 | ||
Does replacement of vitamin D reduce the symptom scores and improve quality of life in patients with chronic urticaria? | Q47983339 | ||
Anxiety and depression seem less common in patients with autoreactive chronic spontaneous urticaria. | Q47995650 | ||
Clinical and etiologic evaluation of the children with chronic urticaria | Q48024231 | ||
Levocetirizine and rupatadine in chronic idiopathic urticaria | Q48055791 | ||
Solar urticaria with an augmentation spectrum in a child | Q48098921 | ||
Omalizumab in pediatric cold contact urticaria: warm blanket for a cold bath? | Q48294350 | ||
Chronic urticaria and irritable bowel syndrome: a cross-sectional study of 11 271 patients | Q48347036 | ||
The EAACI/GA²LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update | Q48517489 | ||
Double dose of cetirizine hydrochloride is effective for patients with urticaria resistant: a prospective, randomized, non-blinded, comparative clinical study and assessment of quality of life | Q48618841 | ||
Autologous whole blood and autologous serum injections are equally effective as placebo injections in reducing disease activity in patients with chronic spontaneous urticaria: a placebo controlled, randomized, single-blind study | Q48621148 | ||
A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria | Q48739101 | ||
Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial | Q34516254 | ||
World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) | Q34589248 | ||
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study | Q34727734 | ||
Evaluation of autologous serum skin test and skin prick test reactivity to house dust mite in patients with chronic spontaneous urticaria | Q34760419 | ||
Clinical management of hereditary angio-oedema in children. | Q34764718 | ||
Chronic urticaria: association with thyroid autoimmunity | Q35571415 | ||
Retrospective case note review of chronic spontaneous urticaria outcomes and adverse effects in patients treated with omalizumab or ciclosporin in UK secondary care | Q35865960 | ||
Resource use and costs in an insured population of patients with chronic idiopathic/spontaneous urticaria | Q35930834 | ||
Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. | Q36496397 | ||
Insect bite-induced hypersensitivity and the SCRATCH principles: a new approach to papular urticaria. | Q36496600 | ||
Incidence of allergic contact sensitization in central Chinese subjects with chronic urticaria | Q36885071 | ||
Association of internalizing disorders and allergies in a child and adolescent psychiatry clinical sample. | Q36960463 | ||
Chronic urticaria: recent advances | Q37038497 | ||
Cold-induced urticaria: challenges in diagnosis and management | Q37077765 | ||
Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis | Q37174205 | ||
AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews | Q37397185 | ||
Does urticaria risk increase in patients with celiac disease? A large population-based cohort study | Q37497617 | ||
EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. | Q37570617 | ||
The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations | Q37605896 | ||
Hypocomplementemic urticarial vasculitis syndrome | Q37634646 | ||
Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper | Q37690393 | ||
Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report | Q37696401 | ||
Prevalence and Risk Factors of Urticaria With a Focus on Chronic Urticaria in Children | Q37702904 | ||
Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system | Q37770847 | ||
Immediate contact skin reactions, an update of Contact Urticaria, Contact Urticaria Syndrome and Protein Contact Dermatitis -- "A Never Ending Story". | Q37781935 | ||
Chronic spontaneous urticaria in children: itching for insight | Q37831967 | ||
Urticaria and bacterial infections. | Q37844317 | ||
The etiology of different forms of urticaria in childhood | Q37867380 | ||
Physical urticaria | Q38015260 | ||
Childhood urticaria | Q38028764 | ||
How not to miss autoinflammatory diseases masquerading as urticaria. | Q38043522 | ||
H(1)-antihistamines and urticaria: how can we predict the best drug for our patient? | Q38044949 | ||
Psychosocial factors and chronic spontaneous urticaria: a systematic review | Q38060190 | ||
Aetiological factors associated with chronic urticaria in children: a systematic review | Q38065969 | ||
Physical urticarias and cholinergic urticaria | Q38164939 | ||
The diagnosis and management of acute and chronic urticaria: 2014 update. | Q38207184 | ||
The prevalence of thyroid autoimmunity in patients with urticaria: a systematic review and meta-analysis | Q38234204 | ||
Antihistamine use in children | Q38242172 | ||
Paediatric mastocytosis: a systematic review of 1747 cases | Q38348047 | ||
Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema | Q38562774 | ||
Serological evidence that activation of ubiquitous human herpesvirus-6 (HHV-6) plays a role in chronic idiopathic/spontaneous urticaria (CIU). | Q38585084 | ||
Chronic Urticaria and the Metabolic Syndrome: a Cross-sectional Community-based Study of 11,261 Patients | Q38605883 | ||
Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus--a systematic review | Q38627179 | ||
Association between urticaria and virus infections: A systematic review | Q38659329 | ||
Epidemiology and comorbidities of patients with chronic urticaria in Taiwan: A nationwide population-based study. | Q38661666 | ||
Quality of life impact of childhood skin conditions measured using the Children's Dermatology Life Quality Index (CDLQI): a meta-analysis. | Q38674403 | ||
A 21-35 kDa Mixed Protein Component from Helicobacter pylori Activates Mast Cells Effectively in Chronic Spontaneous Urticaria | Q38779538 | ||
A Review of International Recommendations for the Diagnosis and Management of Chronic Urticaria | Q38878806 | ||
The persistence of chronic spontaneous urticaria in childhood is associated with the urticaria activity score | Q38944225 | ||
Clinical practice guideline for diagnosis and management of urticaria | Q38968988 | ||
Eczema and Urticaria as Manifestations of Undiagnosed and Rare Diseases | Q39022479 | ||
BSACI guideline for the management of chronic urticaria and angioedema | Q39035835 | ||
Papular urticaria: A review of causal agents in Colombia | Q39043393 | ||
Corticosteroid-related toxicity in patients with chronic idiopathic urticariachronic spontaneous urticaria | Q39119160 | ||
Parasitic Infections in Children with Chronic Spontaneous Urticaria | Q39138914 | ||
Effects of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: Results from a Retrospective Cohort Study | Q39183913 | ||
Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years | Q39185025 | ||
Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: A systematic review | Q39240629 | ||
The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. | Q39289653 | ||
Alternative treatments for chronic spontaneous urticaria beyond the guideline algorithm | Q39326203 | ||
Development, validation, and initial results of the Angioedema Activity Score | Q39371919 | ||
Review of Physical Urticarias and Testing Methods | Q39387473 | ||
Cold urticaria: a 20-year follow-up study | Q39596378 | ||
Prediction of the Efficacy of Antihistamines in Chronic Spontaneous Urticaria Based on Initial Suppression of the Histamine- Induced Wheal | Q39667300 | ||
Sociodemographic and clinical characteristics, causal factors and evolution of a group of patients with chronic urticaria-angioedema. | Q39826628 | ||
High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study | Q39872916 | ||
Epidemiology of urticaria in infants and young children in Germany--results from the German LISAplus and GINIplus Birth Cohort Studies | Q40228148 | ||
A Popular myth - low-histamine diet improves chronic spontaneous urticaria - fact or fiction? | Q40541338 | ||
Cholinergic urticaria: More than a simple inducible urticaria | Q40757269 | ||
Epidemiology of urticaria: a representative cross-sectional population survey | Q48818614 | ||
Levels of depression, anxiety and behavioural problems and frequency of psychiatric disorders in children with chronic idiopathic urticaria | Q48960791 | ||
Treatment of chronic urticaria in children with antihistamines and cyclosporine. | Q50657990 | ||
Performance of the new SLICC classification criteria in childhood systemic lupus erythematosus: a multicentre study. | Q50708723 | ||
Autoantibodies to the high-affinity IgE receptor in children with chronic urticaria. | Q50741466 | ||
Symptomatic dermographism (factitious urticaria)--passive transfer experiments from human to monkey. | Q50902656 | ||
Acute and Chronic Urticaria: Evaluation and Treatment. | Q50911014 | ||
Prevalence of food avoidance and food allergy in Chinese patients with chronic urticaria. | Q50992987 | ||
Positive CD63 Basophil Activation Tests Are Common in Children with Chronic Spontaneous Urticaria and Linked to High Disease Activity. | Q51064858 | ||
The natural history of chronic urticaria in childhood: a prospective study. | Q51127865 | ||
The role of contact allergens in chronic idiopathic urticaria. | Q51335231 | ||
Chronic urticaria and autoimmunity: associations found in a large population study. | Q51360062 | ||
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. | Q51455335 | ||
Chronic urticaria: etiology and natural course in children. | Q51461131 | ||
The clinical and laboratory characteristics of acute spontaneous urticaria and its progression to chronic spontaneous urticaria. | Q51475115 | ||
Correlation between clinical findings and results of autologous serum skin test in patients with chronic idiopathic urticaria. | Q51520536 | ||
Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child. | Q52175025 | ||
Responsiveness and minimal important difference of the urticaria control test. | Q52837975 | ||
The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision. | Q52854801 | ||
Rupatadine 20 mg and 40 mg are Effective in Reducing the Symptoms of Chronic Cold Urticaria. | Q52865997 | ||
Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: case series. | Q52866200 | ||
Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. | Q52879396 | ||
Role of nonallergic hypersensitivity reactions in children with chronic urticaria. | Q52981496 | ||
Omalizumab in Chronic Spontaneous Urticaria: A Brazilian Real-Life Experience. | Q53790793 | ||
[EVALUATION OF DYSFUNCTION IN BLOOD COAGULATION IN CHILDREN WITH URTICARIA]. | Q53990847 | ||
Real-life experiences with omalizumab for the treatment of chronic urticaria. | Q54327169 | ||
Autoimmune chronic spontaneous urticaria: What we know and what we do not know | Q56960651 | ||
A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1 antihistamine-resistant chronic spontaneous urticaria | Q57217219 | ||
Chronic idiopathic urticaria: Comparison of the clinical features of patients with and without anti-FcϵRI or anti-IgE autoantibodies | Q57624893 | ||
Reactivity to autologous serum skintest and clinical features in chronic idiopathic urticaria | Q57999089 | ||
Chronic spontaneous urticaria: immune system, blood coagulation, and more | Q58418332 | ||
Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum | Q58418527 | ||
SIAIP position paper: provocation challenge to antibiotics and non-steroidal anti-inflammatory drugs in children | Q59790515 | ||
Chronic urticaria caused by Hymenolepis nana in an adopted girl | Q61963199 | ||
Etiologic factors in childhood chronic urticaria | Q68199907 | ||
The natural history and response to therapy of chronic urticaria and angioedema | Q69369855 | ||
A serological mediator in chronic idiopathic urticaria--a clinical, immunological and histological evaluation | Q69540059 | ||
Chronic urticaria in childhood: natural course and etiology | Q71817338 | ||
Lambert–Eaton Myasthenic syndrome in a child with an autoimmune phenotype | Q73301043 | ||
Practice guidelines developed by specialty societies: the need for a critical appraisal | Q73449679 | ||
Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria | Q74308264 | ||
The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria | Q77418033 | ||
The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema | Q77753386 | ||
TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction | Q77902735 | ||
A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases | Q79771819 | ||
Characterization of irritable bowel syndrome and constipation in children with allergic diseases | Q79898296 | ||
P433 | issue | 1 | |
P921 | main subject | urticaria | Q187440 |
chronic urticaria | Q3886240 | ||
P304 | page(s) | 101 | |
P577 | publication date | 2019-08-15 | |
P1433 | published in | Italian Journal of Paediatrics | Q15762169 |
P1476 | title | Management of chronic urticaria in children: a clinical guideline | |
P478 | volume | 45 |
Q94453366 | [Urticaria in children] | cites work | P2860 |
Search more.